top of page
Entacapone

Mechanism of action:
Entacapone is a catechol-O-methyltransferase inhibitor and is commonly used as an adjunct to levodopa. Peripheral catechol-O-methyltransferase breaks down levodopa, reducing the amount that can enter the central nervous system. Entacapone inhibits peripheral catechol-O-methyltransferase activity, allowing more levodopa to reach the central nervous system and be converted into dopamine, thereby increasing the proportion of centrally available levodopa and modulating dopamine-related signaling.
Reference(s):
1. Najib J et al. (2001). Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's disease. Clin Ther.
2. Chong BS et al. (2000). Entacapone. Ann Pharmacother.
bottom of page
